Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design

  • Hiroshi Wada,
  • Atsushi Shimizu,
  • Toshihiro Osada,
  • Yuki Tanaka,
  • Satoshi Fukaya,
  • Eiji Sasaki

Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design

  • Hiroshi Wada, 
  • Atsushi Shimizu, 
  • Toshihiro Osada, 
  • Yuki Tanaka, 
  • Satoshi Fukaya, 
  • Eiji Sasaki
PLOS
x

There are typographical errors in the fourth and fifth sentences of the Abstract. “IFN-μ” should appear as “IFN-γ.” The correct sentences are: However, to confirm whether a multivalent vaccine can induce an individual epitope-specific CTL, the only viable screening strategies currently available are interferon-gamma (IFN-γ enzyme-linked immunospot (ELISPOT) assays using human peripheral blood mononuclear cells, or expensive human leukocyte antigen (HLA)-expressing mice. In this report, we evaluated the use of our developed murine-20S immunoproteasome (i20S) digestion assay and found that it could predict the results of IFN-γ ELISPOT assays.

There is a typographical error in the Abbreviations. “IFN-μΛ, interferon-gamma” should appear as “IFN-γ, interferon-gamma.”

Reference

  1. 1. Wada H, Shimizu A, Osada T, Tanaka Y, Fukaya S, Sasaki E (2018) Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design. PLoS ONE 13(7): e0199249. https://doi.org/10.1371/journal.pone.0199249 pmid:29969453